OLSALAZINE VERSUS PLACEBO IN THE TREATMENT OF MILD TO MODERATE ULCERATIVE-COLITIS - A RANDOMIZED DOUBLE-BLIND TRIAL

被引：49

作者：

FEURLE, GE

THEUER, D

VELASCO, S

BARRY, BA

WORDEHOFF, D

SOMMER, A

JANTSCHEK, G

KRUIS, W

机构：

[1] FRANKFURT HOCHST, PRAXIS DILLINGEN, HEILBRONN, GERMANY

[2] UNIV COLOGNE, MED KLIN, D-5000 COLOGNE 41, GERMANY

[3] ST MICHAEL KRANKENHAUS, VOLKLINGEN, GERMANY

[4] UNIV LUBECK, MED KLIN, LUBECK, GERMANY

来源：

GUT | 1989年 / 30卷 / 10期

关键词：

D O I：

10.1136/gut.30.10.1354

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

收藏

页码：1354 / 1361

页数：8

相关论文

共 38 条

[1] AZADKHAN AK, 1977, LANCET, V2, P892
[2] BARON JH, 1962, LANCET, V1, P1094
[3] BARTALSKY A, 1982, LANCET, V1, P960
[4] INDUCTION OF AND ADAPTATION TO OLSALAZINE INDUCED INTESTINAL VOLUME LOAD
BERGLINDH, T
LANDSTROM, E
BERGQVIST, E
[J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1988, 23 : 24 - 28
[5] SOLUBLE FUNCTIONAL POLYMERS .3. A POLYMERIC DRUG FOR TREATMENT OF INFLAMMATORY BOWEL-DISEASE
BROWN, JP
MCGARRAUGH, GV
PARKINSON, TM
WINGARD, RE
ONDERDONK, AB
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1983, 26 (09) : 1300 - 1307
[6] CELLO JP, 1983, GASTROINTESTINAL DIS, P1112
[7] CHAN RP, 1983, DIGEST DIS SCI, V18, P107
[8] CLINICAL PHARMACOKINETICS OF SULFASALAZINE
DAS, KM
DUBIN, R
[J]. CLINICAL PHARMACOKINETICS, 1976, 1 (06) : 406 - 425
[9] ADVERSE REACTIONS DURING SALICYLAZOSULFAPYRIDINE THERAPY AND RELATION WITH DRUG-METABOLISM AND ACETYLATOR PHENOTYPE
DAS, KM
EASTWOOD, MA
MCMANUS, JPA
SIRCUS, W
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1973, 289 (10) : 491 - 495
[10] AN ORAL PREPARATION TO RELEASE DRUGS IN THE HUMAN-COLON
DEW, MJ
HUGHES, PJ
LEE, MG
EVANS, BK
RHODES, J
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 (03) : 405 - 408

← 1 2 3 4 →